{"id":8208,"date":"2021-12-16T12:24:46","date_gmt":"2021-12-16T17:24:46","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/thymosin-%ce%b11-thymosin-%ce%b11-acetatetymosin-alpha-1-cas-162304-98-7-for-att-behandla-kronisk-hepatit-b-och-starka-immunforsvaret\/"},"modified":"2021-12-16T12:24:46","modified_gmt":"2021-12-16T17:24:46","slug":"thymosin-%ce%b11-thymosin-%ce%b11-acetatetymosin-alpha-1-cas-162304-98-7-for-att-behandla-kronisk-hepatit-b-och-starka-immunforsvaret","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/sv\/product\/thymosin-%ce%b11-thymosin-%ce%b11-acetatetymosin-alpha-1-cas-162304-98-7-for-att-behandla-kronisk-hepatit-b-och-starka-immunforsvaret\/","title":{"rendered":"Thymosin \u03b11\/ Thymosin \u03b11 \/ AcetateTymosin Alpha 1 CAS 162304-98-7 F\u00f6r att behandla kronisk hepatit B och st\u00e4rka immunf\u00f6rsvaret"},"content":{"rendered":"<h2><strong>Thymosin \u03b11\/ Thymosin \u03b11 \/ AcetateTymosin Alpha 1 CAS 162304-98-7 F\u00f6r att behandla kronisk hepatit B och st\u00e4rka immunf\u00f6rsvaret<\/strong><\/h2>\n<p>Produktnamn: Thymosin \u03b11<br \/>\nSekvens: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu -Lys-Glu-Val-Glu-Glu-Ala-Glu-Ala-Glu-Asn-OH<br \/>\nSynonymer: THYMOSIN ALPHA 1;THYMOSIN ALPHA1 N\u00f6tkreatur;TYMOSIN APHA 1;ZADAXIN;Tymosin \u03b11 Acetate;Tymosin; Acetatsalt;Tymosin \u03b1 1 Acetat(Tymalfasin)<br \/>\nCAS: 62304-98-7<br \/>\nMF: C129H215N33O55<br \/>\nMW: 3108.32<br \/>\nEINECS: 1592732-453-0 AminoProduct Acids Kategorier:&amp;&gt; Derivat;Peptid;Various Peptides<br \/>\nMol Fil: 62304-98-7.mol<\/p>\n<p>Tymosin-\u03b11 (T-\u03b11), en syntetisk peptid med 28 aminosyror med flera biologiska aktiviteter fr\u00e4mst riktade mot immunsvar f\u00f6rb\u00e4ttring, detta l\u00e4kemedel anv\u00e4nds f\u00f6r behandling av HBV- och hepatit C-virus (HCV)-infektioner och utvecklas f\u00f6r behandling av icke-sm\u00e5cellig lungcancer (NSCLC), hepatocellul\u00e4rt karcinom, AIDS och malignt melanom. T-\u03b11 kan potentiera effekten av cytokiner och \u00e4ven minska den hematologiska toxiciteten av cytotoxisk l\u00e4kemedelsbehandling, s\u00e5som cyklofosfamid, 5-fluorouracil, dacarbazin.<\/p>\n<p> <strong>Thymosin \u03b11\/ Thymosin \u03b11 \/ AcetateThymosin Alpha 1 CAS 162304- 98-7 Kemiska egenskaper<\/strong><br \/>\nKokpunkt 2899,7\u00b165,0 \u00b0C(F\u00f6rutsp\u00e5dd)<br \/>\ndensitet 1,360\u00b10,06 g\/cm3(F\u00f6rutsp\u00e5dd)<br \/>\nlagringstemp. \u221220\u00b0C<br \/>\nl\u00f6slighet Det rekommenderas att rekonstituera den lyofiliserade Thymosin a1 i steril 18M\u03a9-cm H2O, inte mindre \u00e4n 100 \u03bcg\/ml, som sedan kan sp\u00e4das ytterligare till andra vattenl\u00f6sningar.<br \/>\nf\u00e4rg Steril Filtrerad Vit frystorkad (frystorkat) pulver.<br \/>\nStabilitet: Lyofiliserat Thymosin a1, \u00e4ven om det \u00e4r stabilt i rumstemperatur i 3 veckor, b\u00f6r det f\u00f6rvaras uttorkat under -18\u00b0C. Efter beredning b\u00f6r tymalfasin f\u00f6rvaras vid 4\u00b0C mellan 2-7 dagar och f\u00f6r framtida anv\u00e4ndning under -18\u00b0C.<br \/>\nF\u00f6r l\u00e5ngtidsf\u00f6rvaring rekommenderas att tills\u00e4tta ett b\u00e4rarprotein (0,1 % HSA eller BSA).&lt;&amp; &gt;Var v\u00e4nlig f\u00f6rhindra frys-upptiningscykler.<\/p>\n<p> <strong>Funktion och till\u00e4mpning av Thymosin \u03b11\/ Thymosin \u03b11 \/ AcetateThymosin Alpha 1 CAS 162304-98-7<\/strong><br \/>\nTymosin \u03b11 \u00e4r ett kemiskt syntetiserat tymosin \u03b11 som \u00e4r identiskt med m\u00e4nskligt tymosin \u03b11. Tymosin al \u00e4r en acetylerad polypeptid. Thymosin \u03b11 \u00e4r f\u00f6r n\u00e4rvarande godk\u00e4nd f\u00f6r behandling av hepatit B och C i 35 utvecklingsl\u00e4nder. Dessutom anv\u00e4nds tymosin \u03b11 f\u00f6r att f\u00f6rst\u00e4rka immunsvaret vid behandling av andra sjukdomar.<\/p>\n<p> <strong>F\u00f6rdelar med tymosin alfa 1<\/strong><br \/>\nTymalfasin (tymosin-alfa 1) \u00e4r ett immunmodulerande medel som kan f\u00f6rst\u00e4rka Thl-immunsvaret. In vitro: konjugering av tymalfasin (T\u03b11) med iRGD bevarar l\u00e4kemedlets immunmodulerande aktivitet genom att \u00f6ka proliferationen av musmj\u00e4ltlymfocyter. J\u00e4mf\u00f6rt med Tal-behandling \u00f6kar Tal-iRGD-behandling av MCF-7-celler avsev\u00e4rt antalet celler som genomg\u00e5r apoptos, vilket resulterar i en dosberoende h\u00e4mning av cancercelltillv\u00e4xt. <\/p>\n<p>In vivo: Tymalfasin har visat sig ha effekt i flera experimentella modeller av immundysfunktion, huvudsakligen infektionssjukdomar som hepatit (tr\u00e4sn\u00e4cka) och influensa (mus), och cancer som melanom (mus) och kolorektal karcinom (r\u00e5tta) d\u00e4r tymalfasin har visat antitum\u00f6reffekter. <\/p>\n<p> <strong>Thymosin alpha 1 Dosering<\/strong><br \/>\nDetta beror p\u00e5 din kroppsvikt. All forskning som hittills genomf\u00f6rts har anv\u00e4nt gnagarstudier, r\u00e5ttorna och m\u00f6ssen injiceras vanligtvis med en effektiv dos som tros vara runt 10 \u03bcg (mcg) per kg, hos m\u00e4nniskor tros detta vara runt motsvarande belastning p\u00e5 1,6 \u03bcg per kg hos m\u00e4nniskor, s\u00e5 om du \u00e4r: <\/p>\n<p>60 kg (132 lb.) s\u00e5 skulle din ideala dagliga orala BPC-157-dos vara 96 \u03bcg (mcg)<br \/>\n70 kg (154 lb.) = &gt; 112 \u03bcg<br \/>\n80 KG (176 lb.) =&gt; 128 \u03bcg<br \/>\n90 KG (198 lb.) =&gt; 144 \u03bcg<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Produktnamn: Thymosin \u03b11<br \/>\nCAS: 62304-98-7<br \/>\nMF: C129H215N33O55<br \/>\nMW: 3108.32<br \/>\nEINECS: 1592732-453-0<br \/>\nMol Fil: 6237.mol-9<\/p>\n","protected":false},"featured_media":2112,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[367],"product_tag":[1472],"class_list":{"0":"post-8208","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-immunmodulerande-peptid","7":"product_tag-thymosin-1-thymosin-1-acetatethymosin-alpha-1-cas-162304-98-7-for-treat-chronic-hepatitis-b-and-boosting-the-immune-system-sv","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product\/8208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/comments?post=8208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/media\/2112"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/media?parent=8208"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_brand?post=8208"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_cat?post=8208"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_tag?post=8208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}